DSIP
Emideltide, DSIP nonapeptide, Delta sleep-inducing peptide
A neuropeptide that induces delta sleep, reduces stress, modulates hormone release, and exhibits antioxidant effects in various physiological processes.
Completed
PHASE2
NCT05328154
MAGnesium Effect With ANtiosteoporotic Drugs
University Hospital, Clermont-Ferrand
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT01638403
Effects of BF2.649 in the Treatment of Excessive Daytime Sleepiness in Narcolepsy.
Bioprojet
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE1
NCT01239888
Oxytocin and Tibolone Adjuncts in Treatment Resistant Depression - A Pilot Study
The Alfred
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT00407511
Pregabalin Treatment Of Peripheral Neuropathic Pain Associated With Diabetic Peripheral NeP (DPN), Postherpetic Neuralgia (PHN), HIV-related NeP (HIV), and Chemotherapy Induced NeP
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT07277465
Role of the Microbiota in Obesity: Effect After Bariatric Surgery
Celia Bañuls
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE4
NCT00203996
Polycystic Ovary Syndrome (PCOS) and Sleep Apnea
University of Chicago
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE4
NCT06906549
Evaluation of 200 mg of Rituximab Every 6 Months as Maintenance Treatment of Rituximab-treated Patients With Rheumatoid Arthritis
University Hospital, Strasbourg, France
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT05161871
Transcranial Direct Current Stimulation Plus Monoclonal Antibodies Acting on the CGRP Pathway for Migraine
University of L'Aquila
INTERVENTIONAL
Updated Dec 15, 2025
Recruiting
PHASE4
NCT05408247
A Randomised Controlled Trial of N-acetylcysteine for the Management of Alcohol Use Disorder
University of Sydney
INTERVENTIONAL
Updated Dec 15, 2025
Unknown
PHASE4
NCT05502731
Januse Kinase Inhibition With Filgotinib to Silence Autoreactive B Cells in Rheumatoid Arthritis
Leiden University Medical Center
INTERVENTIONAL
Updated Dec 15, 2025
Not Yet Recruiting
PHASE3
NCT06212765
Oral Citrulline Supplementation in COPD Patients With Malnutrition
University Hospital, Grenoble
INTERVENTIONAL
Updated Dec 15, 2025
Not Yet Recruiting
NA
NCT06795464
Effectiveness of Immersive Virtual Reality on Biomarkers and Clinical and Clinimetric Variables in Patients with Persistent Shoulder Pain
Universidad Francisco de Vitoria
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE2
NCT04631016
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Assess MEDI3506 in Participants With COPD and Chronic Bronchitis
AstraZeneca
INTERVENTIONAL
Updated Dec 15, 2025
Completed
NA
NCT05771441
Effects of Neck Stabilization Exercise With Heat Therapies
Hilal Yeşil
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT05029921
A Study of Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's Disease
Janssen Research & Development, LLC
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE3
NCT00507416
Velcade,Thalidomide, and Dexamethasone Versus Velcade and Dexamethasone Versus Velcade, Melphalan, and Prednisone
Millennium Pharmaceuticals, Inc.
INTERVENTIONAL
Updated Dec 15, 2025
Terminated
PHASE2
NCT01006616
Long-Term Study of the Effects of Navarixin (SCH 527123, MK-7123) in Participants With Moderate to Severe COPD (MK-7123-019)
Merck Sharp & Dohme LLC
INTERVENTIONAL
Updated Dec 15, 2025
Active Not Recruiting
NCT05991609
Extreme Morphology and Metabolic Health
University of Bath
OBSERVATIONAL
Updated Dec 15, 2025
Recruiting
NA
NCT07262788
A Feasibility Study of Optimal Non-Pharmacological Lifestyle Modifications in People With Type 2 Diabetes
Steno Diabetes Center Copenhagen
INTERVENTIONAL
Updated Dec 15, 2025
Completed
PHASE4
NCT01430403
Preventative Omalizumab or Step-up Therapy for Severe Fall Exacerbations
National Institute of Allergy and Infectious Diseases (NIAID)
INTERVENTIONAL
Updated Dec 15, 2025